Pfizer Could Prove Underrated GLP-1 Stock Opportunity
Pfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
Choosing between cash back and points credit cards can affect your financial rewards. Analyze the pros and cons to make an informed decision.
25,473 articlesPfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
Workday posted a solid Q4 beat on earnings and revenue, yet forward guidance disappointed investors. Shares tumbled a...
Investors eye SpaceX's potential IPO as the space economy broadens; public peers already provide exposure across laun...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...
C3.ai reports after the bell, with traders watching for signals on revenue, margins and AI platform uptake. This live...
A California-based, $1 million dividend portfolio faces notable after-tax headwinds. This analysis compares federal a...
Tesla delivered 480,126 vehicles in Q2 2026, topping estimates by 74,000 and signaling a rebound in EV demand. The fo...
This piece examines which stocks people actually search for and why those trends matter. Learn how to separate curios...
A major hedge fund shift has sparked fresh questions about Privia Health. This article dives into what the move signa...
Retail investors often wonder if congressional trades offer investing clues. This guide explains what "members congre...
Two U.S. startups, Archer Aviation and Joby Aviation, are racing to pioneer urban air mobility. This guide breaks dow...
When a CEO optimizes liquidity by selling shares, it sparks questions. This guide dives into xometry's (xmtr) recentl...